You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CCCC Exercise Disclosure
Adams Kendra · SEC Form 4 · Filed Sep 21, 2026
Exercise
Calculated transaction value
$0
Adams Kendra Chief Financial Officer
CCCC
C4 Therapeutics
CCCC
Transaction date
Sep 18, 2026
Public filing date
Sep 21, 2026
Filing lag
Filed 3 days later
CCCC daily price context
Close on/before transaction
$3.39
Sep 18, 2026
First close after public filing
$3.31
Sep 22, 2026
30-day return after filing
-4.23%
Through Oct 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,250 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001470831-26-000895
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$9.41K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| C4 Therapeutics, Inc. CCCC Current | Exercise | Sep 18, 2026 | $0 |
| C4 Therapeutics, Inc. CCCC | Disposition | Sep 18, 2026 | $9.41K |